line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,LALPATHLAB.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.212102,LALPATHLAB.NS
Normalized EBITDA,2025-03-31 00:00:00,7889000000.0,LALPATHLAB.NS
Total Unusual Items,2025-03-31 00:00:00,,LALPATHLAB.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,,LALPATHLAB.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,4871000000.0,LALPATHLAB.NS
Reconciled Depreciation,2025-03-31 00:00:00,1419000000.0,LALPATHLAB.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,4815000000.0,LALPATHLAB.NS
EBITDA,2025-03-31 00:00:00,7889000000.0,LALPATHLAB.NS
EBIT,2025-03-31 00:00:00,6470000000.0,LALPATHLAB.NS
Net Interest Income,2025-03-31 00:00:00,-223000000.0,LALPATHLAB.NS
Interest Expense,2025-03-31 00:00:00,223000000.0,LALPATHLAB.NS
Interest Income,2025-03-31 00:00:00,,LALPATHLAB.NS
Normalized Income,2025-03-31 00:00:00,4871000000.0,LALPATHLAB.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,4871000000.0,LALPATHLAB.NS
Total Expenses,2025-03-31 00:00:00,15661000000.0,LALPATHLAB.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,LALPATHLAB.NS
Diluted Average Shares,2025-03-31 00:00:00,83407534.0,LALPATHLAB.NS
Basic Average Shares,2025-03-31 00:00:00,83293434.0,LALPATHLAB.NS
Diluted EPS,2025-03-31 00:00:00,58.4,LALPATHLAB.NS
Basic EPS,2025-03-31 00:00:00,58.48,LALPATHLAB.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,4871000000.0,LALPATHLAB.NS
Net Income Common Stockholders,2025-03-31 00:00:00,4871000000.0,LALPATHLAB.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,LALPATHLAB.NS
Net Income,2025-03-31 00:00:00,4871000000.0,LALPATHLAB.NS
Minority Interests,2025-03-31 00:00:00,-51000000.0,LALPATHLAB.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,4922000000.0,LALPATHLAB.NS
Net Income Continuous Operations,2025-03-31 00:00:00,4922000000.0,LALPATHLAB.NS
Tax Provision,2025-03-31 00:00:00,1325000000.0,LALPATHLAB.NS
Pretax Income,2025-03-31 00:00:00,6247000000.0,LALPATHLAB.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,-2483000000.0,LALPATHLAB.NS
Special Income Charges,2025-03-31 00:00:00,,LALPATHLAB.NS
Other Special Charges,2025-03-31 00:00:00,,LALPATHLAB.NS
Write Off,2025-03-31 00:00:00,,LALPATHLAB.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-223000000.0,LALPATHLAB.NS
Interest Expense Non Operating,2025-03-31 00:00:00,223000000.0,LALPATHLAB.NS
Interest Income Non Operating,2025-03-31 00:00:00,,LALPATHLAB.NS
Operating Income,2025-03-31 00:00:00,8953000000.0,LALPATHLAB.NS
Operating Expense,2025-03-31 00:00:00,10846000000.0,LALPATHLAB.NS
Other Operating Expenses,2025-03-31 00:00:00,4603000000.0,LALPATHLAB.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,1419000000.0,LALPATHLAB.NS
Amortization,2025-03-31 00:00:00,,LALPATHLAB.NS
Depreciation Income Statement,2025-03-31 00:00:00,1419000000.0,LALPATHLAB.NS
Selling General And Administration,2025-03-31 00:00:00,,LALPATHLAB.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,LALPATHLAB.NS
General And Administrative Expense,2025-03-31 00:00:00,,LALPATHLAB.NS
Rent And Landing Fees,2025-03-31 00:00:00,,LALPATHLAB.NS
Gross Profit,2025-03-31 00:00:00,19799000000.0,LALPATHLAB.NS
Cost Of Revenue,2025-03-31 00:00:00,4815000000.0,LALPATHLAB.NS
Total Revenue,2025-03-31 00:00:00,24614000000.0,LALPATHLAB.NS
Operating Revenue,2025-03-31 00:00:00,24614000000.0,LALPATHLAB.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,LALPATHLAB.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.283284,LALPATHLAB.NS
Normalized EBITDA,2024-03-31 00:00:00,6785000000.0,LALPATHLAB.NS
Total Unusual Items,2024-03-31 00:00:00,103900000.0,LALPATHLAB.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,103900000.0,LALPATHLAB.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,3577000000.0,LALPATHLAB.NS
Reconciled Depreciation,2024-03-31 00:00:00,1436000000.0,LALPATHLAB.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,4514000000.0,LALPATHLAB.NS
EBITDA,2024-03-31 00:00:00,6785000000.0,LALPATHLAB.NS
EBIT,2024-03-31 00:00:00,5349000000.0,LALPATHLAB.NS
Net Interest Income,2024-03-31 00:00:00,-294000000.0,LALPATHLAB.NS
Interest Expense,2024-03-31 00:00:00,294000000.0,LALPATHLAB.NS
Interest Income,2024-03-31 00:00:00,554300000.0,LALPATHLAB.NS
Normalized Income,2024-03-31 00:00:00,3577000000.0,LALPATHLAB.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,3577000000.0,LALPATHLAB.NS
Total Expenses,2024-03-31 00:00:00,14479000000.0,LALPATHLAB.NS
Rent Expense Supplemental,2024-03-31 00:00:00,271690000.0,LALPATHLAB.NS
Diluted Average Shares,2024-03-31 00:00:00,83224756.0,LALPATHLAB.NS
Basic Average Shares,2024-03-31 00:00:00,83089431.0,LALPATHLAB.NS
Diluted EPS,2024-03-31 00:00:00,42.98,LALPATHLAB.NS
Basic EPS,2024-03-31 00:00:00,43.05,LALPATHLAB.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,3577000000.0,LALPATHLAB.NS
Net Income Common Stockholders,2024-03-31 00:00:00,3577000000.0,LALPATHLAB.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,LALPATHLAB.NS
Net Income,2024-03-31 00:00:00,3577000000.0,LALPATHLAB.NS
Minority Interests,2024-03-31 00:00:00,-46000000.0,LALPATHLAB.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,3623000000.0,LALPATHLAB.NS
Net Income Continuous Operations,2024-03-31 00:00:00,3623000000.0,LALPATHLAB.NS
Tax Provision,2024-03-31 00:00:00,1432000000.0,LALPATHLAB.NS
Pretax Income,2024-03-31 00:00:00,5055000000.0,LALPATHLAB.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,-2438000000.0,LALPATHLAB.NS
Special Income Charges,2024-03-31 00:00:00,-70000.0,LALPATHLAB.NS
Other Special Charges,2024-03-31 00:00:00,-7110000.0,LALPATHLAB.NS
Write Off,2024-03-31 00:00:00,7180000.0,LALPATHLAB.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-294000000.0,LALPATHLAB.NS
Interest Expense Non Operating,2024-03-31 00:00:00,294000000.0,LALPATHLAB.NS
Interest Income Non Operating,2024-03-31 00:00:00,554300000.0,LALPATHLAB.NS
Operating Income,2024-03-31 00:00:00,7787000000.0,LALPATHLAB.NS
Operating Expense,2024-03-31 00:00:00,9965000000.0,LALPATHLAB.NS
Other Operating Expenses,2024-03-31 00:00:00,4284000000.0,LALPATHLAB.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,1436000000.0,LALPATHLAB.NS
Amortization,2024-03-31 00:00:00,601460000.0,LALPATHLAB.NS
Depreciation Income Statement,2024-03-31 00:00:00,1436000000.0,LALPATHLAB.NS
Selling General And Administration,2024-03-31 00:00:00,1956210000.0,LALPATHLAB.NS
Selling And Marketing Expense,2024-03-31 00:00:00,733490000.0,LALPATHLAB.NS
General And Administrative Expense,2024-03-31 00:00:00,1222720000.0,LALPATHLAB.NS
Rent And Landing Fees,2024-03-31 00:00:00,271690000.0,LALPATHLAB.NS
Gross Profit,2024-03-31 00:00:00,17752000000.0,LALPATHLAB.NS
Cost Of Revenue,2024-03-31 00:00:00,4514000000.0,LALPATHLAB.NS
Total Revenue,2024-03-31 00:00:00,22266000000.0,LALPATHLAB.NS
Operating Revenue,2024-03-31 00:00:00,22266000000.0,LALPATHLAB.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,-9897652.016857,LALPATHLAB.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.298842,LALPATHLAB.NS
Normalized EBITDA,2023-03-31 00:00:00,5348650000.0,LALPATHLAB.NS
Total Unusual Items,2023-03-31 00:00:00,-33120000.0,LALPATHLAB.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,-33120000.0,LALPATHLAB.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,2388480000.0,LALPATHLAB.NS
Reconciled Depreciation,2023-03-31 00:00:00,1501930000.0,LALPATHLAB.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,7291860000.0,LALPATHLAB.NS
EBITDA,2023-03-31 00:00:00,5315530000.0,LALPATHLAB.NS
EBIT,2023-03-31 00:00:00,3813600000.0,LALPATHLAB.NS
Net Interest Income,2023-03-31 00:00:00,-43550000.0,LALPATHLAB.NS
Interest Expense,2023-03-31 00:00:00,375330000.0,LALPATHLAB.NS
Interest Income,2023-03-31 00:00:00,331780000.0,LALPATHLAB.NS
Normalized Income,2023-03-31 00:00:00,2411702347.983143,LALPATHLAB.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,2388480000.0,LALPATHLAB.NS
Total Expenses,2023-03-31 00:00:00,16651790000.0,LALPATHLAB.NS
Rent Expense Supplemental,2023-03-31 00:00:00,248960000.0,LALPATHLAB.NS
Diluted Average Shares,2023-03-31 00:00:00,83117942.0,LALPATHLAB.NS
Basic Average Shares,2023-03-31 00:00:00,82864443.0,LALPATHLAB.NS
Diluted EPS,2023-03-31 00:00:00,28.74,LALPATHLAB.NS
Basic EPS,2023-03-31 00:00:00,28.82,LALPATHLAB.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,2388480000.0,LALPATHLAB.NS
Net Income Common Stockholders,2023-03-31 00:00:00,2388480000.0,LALPATHLAB.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,LALPATHLAB.NS
Net Income,2023-03-31 00:00:00,2388480000.0,LALPATHLAB.NS
Minority Interests,2023-03-31 00:00:00,-22290000.0,LALPATHLAB.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,2410770000.0,LALPATHLAB.NS
Net Income Continuous Operations,2023-03-31 00:00:00,2410770000.0,LALPATHLAB.NS
Tax Provision,2023-03-31 00:00:00,1027500000.0,LALPATHLAB.NS
Pretax Income,2023-03-31 00:00:00,3438270000.0,LALPATHLAB.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,300000.0,LALPATHLAB.NS
Special Income Charges,2023-03-31 00:00:00,-97330000.0,LALPATHLAB.NS
Other Special Charges,2023-03-31 00:00:00,-15030000.0,LALPATHLAB.NS
Write Off,2023-03-31 00:00:00,112360000.0,LALPATHLAB.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-43550000.0,LALPATHLAB.NS
Interest Expense Non Operating,2023-03-31 00:00:00,375330000.0,LALPATHLAB.NS
Interest Income Non Operating,2023-03-31 00:00:00,331780000.0,LALPATHLAB.NS
Operating Income,2023-03-31 00:00:00,3514640000.0,LALPATHLAB.NS
Operating Expense,2023-03-31 00:00:00,9359930000.0,LALPATHLAB.NS
Other Operating Expenses,2023-03-31 00:00:00,2135990000.0,LALPATHLAB.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,1501930000.0,LALPATHLAB.NS
Amortization,2023-03-31 00:00:00,604140000.0,LALPATHLAB.NS
Depreciation Income Statement,2023-03-31 00:00:00,897790000.0,LALPATHLAB.NS
Selling General And Administration,2023-03-31 00:00:00,1710220000.0,LALPATHLAB.NS
Selling And Marketing Expense,2023-03-31 00:00:00,507800000.0,LALPATHLAB.NS
General And Administrative Expense,2023-03-31 00:00:00,1202420000.0,LALPATHLAB.NS
Rent And Landing Fees,2023-03-31 00:00:00,248960000.0,LALPATHLAB.NS
Gross Profit,2023-03-31 00:00:00,12874570000.0,LALPATHLAB.NS
Cost Of Revenue,2023-03-31 00:00:00,7291860000.0,LALPATHLAB.NS
Total Revenue,2023-03-31 00:00:00,20166430000.0,LALPATHLAB.NS
Operating Revenue,2023-03-31 00:00:00,20166430000.0,LALPATHLAB.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,0.0,LALPATHLAB.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.262371,LALPATHLAB.NS
Normalized EBITDA,2022-03-31 00:00:00,6132000000.0,LALPATHLAB.NS
Total Unusual Items,2022-03-31 00:00:00,37530000.0,LALPATHLAB.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,37530000.0,LALPATHLAB.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,3448000000.0,LALPATHLAB.NS
Reconciled Depreciation,2022-03-31 00:00:00,1081000000.0,LALPATHLAB.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,5023000000.0,LALPATHLAB.NS
EBITDA,2022-03-31 00:00:00,6132000000.0,LALPATHLAB.NS
EBIT,2022-03-31 00:00:00,5051000000.0,LALPATHLAB.NS
Net Interest Income,2022-03-31 00:00:00,-302000000.0,LALPATHLAB.NS
Interest Expense,2022-03-31 00:00:00,302000000.0,LALPATHLAB.NS
Interest Income,2022-03-31 00:00:00,472610000.0,LALPATHLAB.NS
Normalized Income,2022-03-31 00:00:00,3448000000.0,LALPATHLAB.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,3448000000.0,LALPATHLAB.NS
Total Expenses,2022-03-31 00:00:00,13503000000.0,LALPATHLAB.NS
Rent Expense Supplemental,2022-03-31 00:00:00,260560000.0,LALPATHLAB.NS
Diluted Average Shares,2022-03-31 00:00:00,82944431.0,LALPATHLAB.NS
Basic Average Shares,2022-03-31 00:00:00,82685851.0,LALPATHLAB.NS
Diluted EPS,2022-03-31 00:00:00,41.57,LALPATHLAB.NS
Basic EPS,2022-03-31 00:00:00,41.7,LALPATHLAB.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,3448000000.0,LALPATHLAB.NS
Net Income Common Stockholders,2022-03-31 00:00:00,3448000000.0,LALPATHLAB.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,LALPATHLAB.NS
Net Income,2022-03-31 00:00:00,3448000000.0,LALPATHLAB.NS
Minority Interests,2022-03-31 00:00:00,-55000000.0,LALPATHLAB.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,3503000000.0,LALPATHLAB.NS
Net Income Continuous Operations,2022-03-31 00:00:00,3503000000.0,LALPATHLAB.NS
Tax Provision,2022-03-31 00:00:00,1246000000.0,LALPATHLAB.NS
Pretax Income,2022-03-31 00:00:00,4749000000.0,LALPATHLAB.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,-2320000000.0,LALPATHLAB.NS
Special Income Charges,2022-03-31 00:00:00,5910000.0,LALPATHLAB.NS
Other Special Charges,2022-03-31 00:00:00,1050000.0,LALPATHLAB.NS
Write Off,2022-03-31 00:00:00,-6960000.0,LALPATHLAB.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-302000000.0,LALPATHLAB.NS
Interest Expense Non Operating,2022-03-31 00:00:00,302000000.0,LALPATHLAB.NS
Interest Income Non Operating,2022-03-31 00:00:00,472610000.0,LALPATHLAB.NS
Operating Income,2022-03-31 00:00:00,7371000000.0,LALPATHLAB.NS
Operating Expense,2022-03-31 00:00:00,8480000000.0,LALPATHLAB.NS
Other Operating Expenses,2022-03-31 00:00:00,3750000000.0,LALPATHLAB.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,1081000000.0,LALPATHLAB.NS
Amortization,2022-03-31 00:00:00,301420000.0,LALPATHLAB.NS
Depreciation Income Statement,2022-03-31 00:00:00,1081000000.0,LALPATHLAB.NS
Selling General And Administration,2022-03-31 00:00:00,1677860000.0,LALPATHLAB.NS
Selling And Marketing Expense,2022-03-31 00:00:00,367640000.0,LALPATHLAB.NS
General And Administrative Expense,2022-03-31 00:00:00,1310220000.0,LALPATHLAB.NS
Rent And Landing Fees,2022-03-31 00:00:00,260560000.0,LALPATHLAB.NS
Gross Profit,2022-03-31 00:00:00,15851000000.0,LALPATHLAB.NS
Cost Of Revenue,2022-03-31 00:00:00,5023000000.0,LALPATHLAB.NS
Total Revenue,2022-03-31 00:00:00,20874000000.0,LALPATHLAB.NS
Operating Revenue,2022-03-31 00:00:00,20874000000.0,LALPATHLAB.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,LALPATHLAB.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,LALPATHLAB.NS
Normalized EBITDA,2021-03-31 00:00:00,,LALPATHLAB.NS
Total Unusual Items,2021-03-31 00:00:00,-290000.0,LALPATHLAB.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,-290000.0,LALPATHLAB.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,LALPATHLAB.NS
Reconciled Depreciation,2021-03-31 00:00:00,,LALPATHLAB.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,LALPATHLAB.NS
EBITDA,2021-03-31 00:00:00,,LALPATHLAB.NS
EBIT,2021-03-31 00:00:00,,LALPATHLAB.NS
Net Interest Income,2021-03-31 00:00:00,,LALPATHLAB.NS
Interest Expense,2021-03-31 00:00:00,,LALPATHLAB.NS
Interest Income,2021-03-31 00:00:00,438750000.0,LALPATHLAB.NS
Normalized Income,2021-03-31 00:00:00,,LALPATHLAB.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,LALPATHLAB.NS
Total Expenses,2021-03-31 00:00:00,,LALPATHLAB.NS
Rent Expense Supplemental,2021-03-31 00:00:00,148360000.0,LALPATHLAB.NS
Diluted Average Shares,2021-03-31 00:00:00,,LALPATHLAB.NS
Basic Average Shares,2021-03-31 00:00:00,,LALPATHLAB.NS
Diluted EPS,2021-03-31 00:00:00,,LALPATHLAB.NS
Basic EPS,2021-03-31 00:00:00,,LALPATHLAB.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,LALPATHLAB.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,LALPATHLAB.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,LALPATHLAB.NS
Net Income,2021-03-31 00:00:00,,LALPATHLAB.NS
Minority Interests,2021-03-31 00:00:00,,LALPATHLAB.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,LALPATHLAB.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,LALPATHLAB.NS
Tax Provision,2021-03-31 00:00:00,,LALPATHLAB.NS
Pretax Income,2021-03-31 00:00:00,,LALPATHLAB.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,LALPATHLAB.NS
Special Income Charges,2021-03-31 00:00:00,-47580000.0,LALPATHLAB.NS
Other Special Charges,2021-03-31 00:00:00,-3680000.0,LALPATHLAB.NS
Write Off,2021-03-31 00:00:00,51260000.0,LALPATHLAB.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,LALPATHLAB.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,LALPATHLAB.NS
Interest Income Non Operating,2021-03-31 00:00:00,438750000.0,LALPATHLAB.NS
Operating Income,2021-03-31 00:00:00,,LALPATHLAB.NS
Operating Expense,2021-03-31 00:00:00,,LALPATHLAB.NS
Other Operating Expenses,2021-03-31 00:00:00,,LALPATHLAB.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,LALPATHLAB.NS
Amortization,2021-03-31 00:00:00,95880000.0,LALPATHLAB.NS
Depreciation Income Statement,2021-03-31 00:00:00,,LALPATHLAB.NS
Selling General And Administration,2021-03-31 00:00:00,1178880000.0,LALPATHLAB.NS
Selling And Marketing Expense,2021-03-31 00:00:00,307210000.0,LALPATHLAB.NS
General And Administrative Expense,2021-03-31 00:00:00,871670000.0,LALPATHLAB.NS
Rent And Landing Fees,2021-03-31 00:00:00,148360000.0,LALPATHLAB.NS
Gross Profit,2021-03-31 00:00:00,,LALPATHLAB.NS
Cost Of Revenue,2021-03-31 00:00:00,,LALPATHLAB.NS
Total Revenue,2021-03-31 00:00:00,,LALPATHLAB.NS
Operating Revenue,2021-03-31 00:00:00,,LALPATHLAB.NS
